Epigenetic regulation of the 1,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1) in colon cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 136, Issue 1, 2013, Pages 296-299

  Höbaus, Julia ^a   Fetahu, Irfete Sh ^a   Khorchide, Maya ^a   Manhardt, Teresa ^a   Kallay, Enikö ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

5 Aza 2 deoxycytidine; CYP24A1; Epigenetics; Histone deacetylase inhibitors; Methylation; Trichostatin A

Indexed keywords

1,25 DIHYDROXYVITAMIN D3 24 HYDROXYLASE; 5 AZA 2' DEOXYCYTIDINE; CALCITRIOL; MESSENGER RNA; OXYGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ARTICLE; COLON CANCER; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; ENZYME INHIBITION; EPIGENETICS; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROMOTER REGION; TREATMENT RESPONSE; UPREGULATION;

EID: 84881153075     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.08.003     Document Type: Article

References (11)

1. D.M. Peehl, R.J. Skowronski, G.K. Leung, S.T. Wong, T.A. Stamey, D. Feldman, Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells, Cancer Research 54 (3) (1994) 805-810.
2. G. Flynn, I. Chung, W.D. Yu, M. Romano, R.A. Modzelewski, C.S. Johnson, D.L. Trump, Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis, Oncology 70 (6) (2006) 447-457.
3. E. Giovannucci, Y. Liu, E.B. Rimm, B.W. Hollis, C.S. Fuchs, M.J. Stampfer, W.C. Willett, Prospective study of predictors of vitamin D status and cancer incidence and mortality in men, Journal of the National Cancer Institute 98 (7) (2006) 451-459.
4. M.G. Anderson, M. Nakane, X. Ruan, P.E. Kroeger, J.R. Wu-Wong, Expression of VDR and CYP24A1 mRNA in human tumors, Cancer Chemotherapy and Pharmacology 57 (2) (2006) 234-240.
5. W. Luo, A.R. Karpf, K.K. Deeb, J.R. Muindi, C.D. Morrison, C.S. Johnson, D.L. Trump, Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer, Cancer Research 70 (14) (2010) 5953-5962.
6. H.C. Horváth, P. Lakatos, J.P. Kósa, K. Bácsi, K. Borka, G. Bises, T. Nittke, P.A. Hershberger, G. Speer, E. Kállay, The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis, Journal of Histochemistry and Cytochemistry 58 (3) (2010) 277-285.
7. D. Lechner, E. Kállay, H.S. Cross, 1Alpha 25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells, Molecular and Cellular Endocrinology 263 (1-2) (2007) 55-64.
8. X. Zhang, A. Krutchinsky, A. Fukuda, W. Chen, S. Yamamura, B.T. Chait, R.G. Roeder, MED1/TRAP220 exists predominantly in a TRAP/mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription, Molecular Cell 19 (1) (2005) 89-100.
9. M. Khorchide, D. Lechner, H.S. Cross, Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells, Journal of Steroid Biochemistry and Molecular Biology 93 (2-5) (2005) 167-172.
10. M.B. Meyer, P.D. Goetsch, J.W. Pike, A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha 25-dihydroxyvitamin D3, Journal of Biological Chemistry 285 (20) (2010) 15599-15610.
11. J.M. Matilainen, M. Malinen, M.M. Turunen, C. Carlberg, S. Väisänen, The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells, Journal of Biological Chemistry 285 (31) (2010) 24174-24183.